首页> 美国卫生研究院文献>Journal of Radiosurgery and SBRT >Dosimetric comparison of intracranial metastasis treatment using two radiosurgery systems: TrueBeam STx with VMAT and Gamma Knife Model 4C
【2h】

Dosimetric comparison of intracranial metastasis treatment using two radiosurgery systems: TrueBeam STx with VMAT and Gamma Knife Model 4C

机译:使用两种放射外科系统进行颅内转移治疗的剂量学比较:配备VMAT的TrueBeam STx和4C型伽玛刀

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We compared treatment plan quality based on target coverage and normal brain tissue sparing for two intracranial stereotactic radiosurgery systems: TrueBeam STx using VMAT and Gamma Knife (GK). Ten patients with 24 tumors (seven with 1-2 and three with 4-6 ranging from 0.1 to 20.2 cc), previously treated with GK Model 4C (prescription doses ranging from 14-23 Gy), were re-planned for VMAT using Eclipse treatment planning system. Various photon beam energies and MLC leaf widths with and without jaw tracking were studied to achieve optimal plans. Plan qualities were assessed by target coverages using Paddick Conformity Index (PCI), normal-brain-tissue integral dose (Gy-cc) and sparing. In all cases critical structure dose criteria were met. The average PCI was 0.76±0.21 for VMAT and 0.46±0.20 for GK plans (p≤0.001), respectively. On average 81% reduction of 12 Gy normal-brain-tissue volumes was achieved by VMAT. The average integral dose ratio of GK to VMAT plans was 1.50±0.61 (p=0.006). VMAT was capable of producing higher quality treatment plans in terms of target coverage and normal brain tissue sparing than GK while using optimal beam geometries and optimization techniques.
机译:我们比较了基于目标覆盖率和正常脑组织保留的两种颅内立体定向放射外科手术系统:使用VMAT的TrueBeam STx和伽玛刀(GK)的治疗计划质量。使用Eclipse重新计划了10例先前用GK 4C模型(处方剂量范围为14-23 Gy)治疗的24个肿瘤的患者(七个肿瘤为1-2个,三个肿瘤为4-6,范围从0.1到20.2 cc),重新计划了VMAT的使用。治疗计划系统。研究了具有和不具有颌跟踪的各种光子束能量和MLC叶宽度,以实现最佳计划。计划质量通过使用Paddick合格指数(PCI),正常脑组织总剂量(Gy-cc)和备用的目标覆盖率进行评估。在所有情况下,都符合关键结构剂量标准。 VMAT的平均PCI为0.76±0.21,GK计划的平均PCI为0.46±0.20(p≤0.001)。通过VMAT平均减少了12 Gy正常脑组织体积的81%。 GK与VMAT计划的平均积分剂量比为1.50±0.61(p = 0.006)。在使用最佳射束几何形状和优化技术的同时,VMAT能够在目标覆盖率和正常脑组织保留方面提供比GK更高质量的治疗计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号